PROVIDER PROFILE · NPI 1689610115
Rama PalwaiM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
605
Unique beneficiaries
—
Total services
55,118
Distinct HCPCS
20
Medicare payment
$687K
Peer benchmark
Total Medicare services vs. 382 Rheumatology providers in TX — top quintile (cohort median 13,742).
PRESCRIBING · PART D · 2024
Total Rx claims
831
Beneficiaries
—
Total drug cost
$125K
Distinct drugs
18
Brand share
26.7%
Top prescribed drugs
Methotrexate Sodium152 claims
Prednisone115 claims
Hydroxychloroquine Sulfate96 claims
Tramadol Hcl71 claims
Gabapentin68 claims
QUALITY · MIPS · 2024
Final MIPS score
74.5
Quality
58.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
88.0
Payment adjustment
-0.06%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where Rama Palwai's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX | 77 | 211 |
| Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX | 33 | 106 |
| TOMBALL TEXAS HOSPITAL COMPANY LLC | 21 | 82 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE